Newsletter
Mayo Clinic Talks

Mayo Clinic Talks

Stay on top of your practice with podcasts from colleagues at Mayo Clinic.

Latest From Series

Headache Edition: Migraine Advocacy & Special Considerations in Women

To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course. Guest: Amaal J. Starling, M.D. (@AmaalStarlingMD) Host: Darryl S. Chutka, M.D. (@ChutkaMD) Migraine is four-times more common in women than men and because of migraine predominance in females, it is a significant women’s health issue. Migraine commonly results in loss of productivity and this has a significant economic burden. According to a recent report from the Society for Women’s Health Research, it’s estimated that migraine costs the United States is an estimated $78 billion per year, with women accounting for approximately 80% of the direct medical and lost labor costs.  This podcast will continue our series on headaches and will concentrate on migraine in women. Our guest for this topic is Amaal J. Starling, M.D., a neurologist at the Mayo Clinic in Scottsdale, Arizona. We’ll discuss why migraine is more common in females, how the prevalence changes throughout a woman’s lifetime and specific treatment recommendations for women with migraine. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
June 30, 2022

Cannabidiol (CBD): Discussing Benefits and Risks with Patients

Guest: Thomas P. Pittelkow, D.O., M.P.H. Host: Darryl S. Chutka, M.D. (@ChutkaMD) Cannabidiol (CBD) is a popular natural remedy used for a variety of common ailments and is one of more than 100 chemical compounds called cannabinoids derived from the cannabis plant. Tetrahydrocannabinol (THC) is the main psychoactive cannabinoid found in cannabis. However, unlike THC, CBD does not have psychoactive properties. There are claims this compound treats not only pain, but a variety of mental health issues, symptoms of malignancy and may even have some cardiovascular benefits. Are all these claims true? What’s been proven? What do we know about the safety of this product? We’ll get the answers to these questions as we discuss Cannabidiol (CBD) with Thomas P. Pittelkow, D.O., M.P.H., an anesthesiologist and pain medicine specialist at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
June 28, 2022

Headache Edition: Interdisciplinary Pain Rehabilitation Treatment for Chronic Headache

To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course. Guest: Christopher D. Sletten, Ph.D., L.P. Host: Darryl S. Chutka, M.D. (@ChutkaMD) Chronic headache is one of the more challenging medical conditions primary care providers commonly face. Whereas the traditional medical model views pain as a problem to be treated and relieved, this model often fails when dealing with patients experiencing chronic headaches. On the other hand, the bio-psychosocial model fits patients with chronic headache much better and when this model is used in the management, patients often have a much better outcome. This podcast is another in our series of headaches and will address the use of a cognitive-behavioral approach with an interdisciplinary team in the evaluation and management of patients with chronic headaches. Our guest Christopher D. Sletten, Ph.D., L.P., a psychologist at the Mayo Clinic in Jacksonville, Florida. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
June 23, 2022

COVID-19 Update

This episode is shared from Mayo Clinic Q&A and was recorded in June 2022 Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) As immunity wanes for many vaccinated adults and omicron and its subvariants continue to circulate, it seems that just about everyone knows someone with a case of COVID-19. The steady increase in COVID-19 infections is due to changing, highly contagious variants, explains Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. Dr. Poland says it’s still important to take the precaution of mask-wearing in public areas, even if you have been vaccinated and have received your boosters. "I can’t say it enough. This is so hypercontagious that, regardless of having had three or four doses of vaccine or of having previous COVID-19, you still run an appreciable chance of getting COVID," explains Dr. Poland. "The risk in that case is not of death or hospitalization, but of the complications and long-haul symptoms of COVID-19. And that’s what we’re trying to prevent in people."  For parents, there is positive news this week, as the Food and Drug Administration (FDA) advisory panel voted unanimously to authorize emergency use of the Pfizer and Moderna COVID-19 vaccines for children under 5. For this age group, the Pfizer vaccine will be given in three doses while the Moderna vaccine will be given in two doses. The FDA panel's recommendation now goes to the Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control and Prevention for approval before shots can be administered, possibly beginning as early as next week. On the Mayo Clinic Q&A podcast, Dr. Poland shares the latest COVID-19 news, answers listener questions, and discusses another infectious disease outbreak: monkeypox.  
June 22, 2022

Assessing and Supporting Patients with Alcohol Use Disorder

Guest: Terry D. Schneekloth, M.D. Host: Darryl S. Chutka, M.D. (@ChutkaMD) Unhealthy use of alcohol has the potential to affect not only the individual who consumes the alcohol, but a variety of others as well. Alcohol is the most used addictive substance, with an estimated prevalence of 7% of the United States population. Excessive alcohol use has the potential to cause damage to essentially every organ system and is thought to reduce one’s life expectance by approximately 10 years. Whereas treatment is available and has the potential to be very successful, it often requires an ongoing, lifetime of therapy. Our guest for this podcast is Terry D. Schneekloth, M.D., a psychiatrist and addiction medicine specialist at the Mayo Clinic in Scottsdale, Arizona. This podcast discusses when you should suspect alcoholism in your patients, how to make a diagnosis and which management techniques have been shown to be effective. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
June 21, 2022

Headache Edition: Migraine Treatment

To claim credit for this episode, visit Mayo Clinic Talks Podcast: Headache Edition - Online CME Course. Guest: Fred (Michael) M. Cutrer, M.D. Host: Darryl S. Chutka, M.D. (@ChutkaMD) It is estimated that nearly 40 million individuals in the United States have migraines and they’re responsible for a significant amount of lost productivity and healthcare costs. The estimates of the economic impact of migraines in the United States alone approaches $36 billion per year. Many of our patients struggle with adequate management of their migraines; healthcare providers are often confused about the many treatment options now available. This podcast will review and clarify the various treatments for migraines, both for abortive therapy as well as prevention. Our guest is Fred (Michael) M. Cutrer, M.D., a neurologist and headache specialist at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
June 16, 2022

Mayo Clinic Talks

Stay on top of your practice with podcasts from colleagues at Mayo Clinic.

Curated. Portable. Trusted.

Opinions expressed in the podcast do not necessarily reflect those of Mayo Clinic.
View All Episodes

Host

Darryl Chutka, M.D.

Darryl Chutka, M.D.

Internist | Geriatrician | Educator | Host

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
What Will Variant Sigma Look Like? with Michael T. Osterholm, Ph.D., Regents Professor, Division of Environmental Health Science; Director, Center for Infectious Disease Research and Policy (CIDRAP) University of Minnesota